AU2011213703B2 - Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level - Google Patents
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelInfo
- Publication number
- AU2011213703B2 AU2011213703B2 AU2011213703A AU2011213703A AU2011213703B2 AU 2011213703 B2 AU2011213703 B2 AU 2011213703B2 AU 2011213703 A AU2011213703 A AU 2011213703A AU 2011213703 A AU2011213703 A AU 2011213703A AU 2011213703 B2 AU2011213703 B2 AU 2011213703B2
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- conditions
- diabetes
- increasing
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- DTHNMHAUYICORS-KTKZVXAJSA-N 107444-51-9 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title 1
- 210000004369 Blood Anatomy 0.000 title 1
- 206010012601 Diabetes mellitus Diseases 0.000 title 1
- 102100003818 GCG Human genes 0.000 title 1
- 101710042131 GCG Proteins 0.000 title 1
- 101700071595 GRZ1 Proteins 0.000 title 1
- 101700078733 ZGLP1 Proteins 0.000 title 1
- 230000001668 ameliorated Effects 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011213703A AU2011213703B2 (en) | 2005-01-10 | 2011-08-16 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/643,086 | 2005-01-10 | ||
US60/683,172 | 2005-05-19 | ||
US60/726,880 | 2005-10-14 | ||
AU2011213703A AU2011213703B2 (en) | 2005-01-10 | 2011-08-16 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006205164A Division AU2006205164B2 (en) | 2005-01-10 | 2006-01-09 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2011213703A1 AU2011213703A1 (en) | 2011-09-08 |
AU2011213703B2 true AU2011213703B2 (en) | 2013-08-08 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL184364A0 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
WO2007124461A3 (en) | Glp-1 compounds | |
ZA200706294B (en) | Roflumilast for the treatment of diabetes mellitus | |
IL177232A0 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
IL210856A0 (en) | Combination therapy for the treatment of diabetes and related conditions | |
EP1991218A4 (en) | Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives | |
WO2009020802A3 (en) | Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity | |
EP1771188A4 (en) | Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia | |
HK1087337A1 (en) | Use of a hif-alpha stabilizing agent for the preparation of medicament for treatment of diabetes | |
IL189212A0 (en) | Therapeutic agent for diabetes | |
WO2006053043A3 (en) | Methods of treating diabetes mellitus | |
IL192369A0 (en) | Therapeutic agent for diabetes | |
EP1894588A4 (en) | Needle for medical treatment | |
WO2007080149A8 (en) | Treatment of stressed patients | |
EP1889618A4 (en) | Combined drug for treating diabetes | |
GB0521716D0 (en) | Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases | |
EP1750698A4 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
EP1718294A4 (en) | Methods for treatment of complications of diabetes | |
IL189928A0 (en) | Thiophene derivatives for the treatment of diabetes | |
ZA200405342B (en) | The use of melagatran for the manufacture of a medicament for the treatment of type i diabetes mellitus | |
ZA200705470B (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | |
AU2011213703B2 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | |
IL191208A (en) | Use of fenofibrate or a derivative thereof for the manufacture of a medicament for the treatment of diabetic retinopathy | |
GB0423173D0 (en) | Treatment of diabetes |